ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

STX Shield Therapeutics Plc

1.75
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.75 1.70 1.80 1.75 1.75 1.75 154,707 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.34 13.57M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.75p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £13.57 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.34.

Shield Therapeutics Share Discussion Threads

Showing 3401 to 3425 of 23475 messages
Chat Pages: Latest  147  146  145  144  143  142  141  140  139  138  137  136  Older
DateSubjectAuthorDiscuss
08/6/2019
11:54
I’d be very surprised.
peachie 74
08/6/2019
11:13
Sorry to rain on the parade but I would not be surprised if the share price remains fairly flat upto the FDA decision while the TEVA appeal is outstanding.
starpukka
08/6/2019
08:08
This and also US licensing partnerships are all in place Nobbygnome according to press releases. I guess that they are agreements which are in some detail and like the Norgine arrangement will involve a substantial upfront cash injection. It seems that a big sales effort that follows will massively increase turnover and the profit margins that will put everything on an even keel.
maximus72
07/6/2019
11:02
But they will get pricing in the other major countries in Europe in the not too distant future so sales in Europe will grow rapidly next year if not this year. They are also looking to sign licensing partners in other parts of the world such as China.

As usual you are being a little churlish in your views...

nobbygnome
07/6/2019
10:55
If you're trying to work out why it's not £10 yet, the product is on the market with promotion in the UK and Germany and Sweden. It has no pricing across the other major EU markets. Norgine is a smallish company and they are trying to sell it as an alternative to IV in patients that often go to hospital anyway. That's a modest patient pool. It's a drug that really needs a big sales spend. Until that happens, it's not proven as an investment and, it's not likely to be proven in Europe because neither STX nor Norgine can afford to do it. It really all hangs on the US label and who is promoting it there and how much they are will to spend doing it.
crankyman
07/6/2019
10:40
>> NY Boy

What is your evidence that 'US buyers are finding out about this one'?

nobbygnome
07/6/2019
10:39
Nobby, probably one that sold the other day..and saw the light, bit of a no brainer if FDA follow through, risk reward attractive imo
Everyone do their own research as usual

Maximus72 vols are increasing but not an easy stock to buy large quantities, most investors are accumulating, so I doubt much free stock, this has been going on since the 20’s

ny boy
07/6/2019
10:26
Volumes low and caution from the big boys but I still cannot work this one out it seems to me that the IP has a ring of steel around it and the FDA will certainly approve, if only partial at first as a worst case scenario, then ultimately for extended use. Ferracru is proven and totally impressive. The fact that this oral iron has shown to be at least as good as IV ends any concern.
maximus72
07/6/2019
10:19
Wow. A 4K buy at 120p! Someone keen to pay up...
nobbygnome
07/6/2019
10:12
35 trading days until FDA decision, tick tock, start of next month new buying will be interesting, US buyers are finding about this one too.

Exciting times ahead

ny boy
07/6/2019
09:50
arab3,

Yep, you can never do enough research, starting to pay off with MSYS, are you in these or STX, you don’t have to be, you can just be a nice observer if you like GL

Agree Nobby, 27 July creeping up

ny boy
07/6/2019
09:33
Buying pressure mounting again....
nobbygnome
06/6/2019
21:38
like the guy who bought MSYS ages ago and is off to research it now!
arab3
06/6/2019
21:34
Just idiots
ny boy
06/6/2019
19:05
Well some more mugging going on !
Selling at 110 ??!! Why ?!

peachie 74
06/6/2019
10:15
Just a waiting game now, less investors would want to sell after seeing the same thing happening to other sellers ie. Big time mugging! Right off to research (MSYS), my next minnow, heading for the big time.
ny boy
06/6/2019
08:33
Sometimes you just have to stand back and be amazed at anyone who would sell at this time. No understanding.
maximus72
05/6/2019
15:50
Still trying to figure out why there was selling this morning? More mugging, rinse & repeat each decade since the 20p’s DOH!
ny boy
05/6/2019
15:34
155p trading range in my book before 27th July. 117m shares in issue peanuts.
montyhedge
05/6/2019
15:30
150p initial target for the patient bulls
ny boy
05/6/2019
15:17
120p handle to buy again, can’t stop the buyers pouring in

Who sold 35,000 @ 111p? 🤦🏻‍♂️🤦🏻‍♂️😂

ny boy
05/6/2019
12:09
Fed up with these fake sell offs but enjoying the opportunity to do some early summer shopping again!
ny boy
05/6/2019
11:00
I personally would not underestimate how hard this 120p is to crack. I am not expert with charts, but those caught for the past year holding a huge loss, plus those like many of us holding a decent profit, will be reflecting on the risk / reward dynamics at this price. IMO we are close to the point where the short term risk / reward , running up to a date , less than 2 months away, means a percentage would prefer to step back. Also, those looking to join, may choose to wait now thinking they have missed the opportunity Pre news.We will see.
stoneme
05/6/2019
08:15
Back to the immediate post flotation price around 160 should be possible in next few weeks
maximus72
05/6/2019
07:58
130p’s this week is possible, after another savage mugging of sellers,markets are cranking up again generally!
ny boy
Chat Pages: Latest  147  146  145  144  143  142  141  140  139  138  137  136  Older

Your Recent History

Delayed Upgrade Clock